Shandong Anhong Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ERTAPENEM SODIUM (PROCESS I), with a corresponding US DMF Number 37232.
Remarkably, this DMF maintains an Active status since its submission on August 29, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 30, 2022, and payment made on August 19, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II